Footnote

*Reference: Fitzgerald S, Ryan D, Thornton J, Nogueira RG. Preclinical evaluation of Millipede 088 intracranial aspiration catheter in cadaver and in vitro thrombectomy models. J Neurointerv Surg. 2021 May;13(5):447-452. doi: 10.1136/neurintsurg-2020-016218. Epub 2020 Jun 30. PMID: 32606100; PMCID: PMC8053321.

Advancing stroke treatment

Innovative catheter technology designed for efficient vessel access, with better potential for complete clot ingestion* Footnote

INNOVATION

Scroll to Explore

References

(1) World Stroke Organisation www.world-stroke.org 2020

ABOUT ISCHEMIC STROKE

Stroke is a leading cause of death and adult disability. 1 References
Over 7 million people worldwide will have an ischemic stroke this year and more than 3 million people will die as a result. 1 References

RESEARCH

References

(2) Nogueira et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N. Engl. J. Med. 2016
(3) Goyal et al. Endovascular Thrombectomy after Large-Vessel Ischaemic Stroke: A Meta-Analysis of Individual Patient Data from Five Randomised Trials. The Lancet 2016

UNMET CLINICAL NEED

Despite recent clinical advances in stroke therapy, less than 50% of stroke patients treated today achieve a positive clinical outcome. 2,3 References
The need remains for a simple, repeatable solution to reperfuse occluded brain arteries.

TECHNOLOGY

Footnote

*Fitzgerald S, Ryan D, Thornton J, Nogueira RG. Preclinical evaluation of Millipede 088 intracranial aspiration catheter in cadaver and in vitro thrombectomy models. J Neurointerv Surg. 2021 May;13(5):447-452. doi: 10.1136/neurintsurg-2020-016218. Epub 2020 Jun 30. PMID: 32606100; PMCID: PMC8053321.

OUR COMPANY

Perfuze aims to improve patient outcomes with advanced superbore aspiration technology that simplifies access and clot removal.* Footnote
Located in Galway City in the West of Ireland, Perfuze was co-founded in 2018 by experienced medtech innovators, Wayne Allen and Liam Mullins.

Knowledge